Imaging Techniques for Prostate Cancer

This trial examines how imaging techniques like CT scans and MRI scans (Magnetic Resonance Imaging) can aid in planning a specific type of radiation treatment for prostate cancer, known as high-dose-rate (HDR) brachytherapy. Brachytherapy involves placing radioactive implants near the tumor to deliver radiation directly. The trial seeks to determine if using both CT and MRI for planning can reduce side effects such as urine leakage and pain. Men with confirmed prostate cancer, who have not undergone prior pelvic radiation or a prostate MRI, and are planning to undergo HDR brachytherapy, might be suitable candidates. As an unphased trial, this study provides an opportunity to contribute to innovative research that could enhance future prostate cancer treatments.

Research has shown that MRI scans are generally safe and low risk when safety guidelines are followed. Unlike CT scans, MRIs do not use radiation, making them a safer option in many cases. Studies indicate that MRIs use a magnetic field and radio waves to create detailed images of the body, allowing doctors to see inside without exposing patients to radiation.

However, MRIs carry some risks. People with metal implants or pacemakers need to exercise caution because the magnets in the machine can affect metal objects. For most people, though, MRIs are well-tolerated and not harmful.

CT scans, which are also part of this study, involve some radiation exposure. However, they are commonly used and considered safe when performed correctly. Most people do not experience any issues with CT scans.

Researchers are excited about this trial because it explores the potential of using MRI alongside CT scans for planning HDR brachytherapy in prostate cancer treatment. While the standard approach typically involves just CT scans for imaging, incorporating MRI offers more precise imaging capabilities. This can lead to better-targeted radiation therapy, potentially improving treatment outcomes and reducing side effects. By comparing the two approaches, researchers hope to determine if adding MRI can enhance the effectiveness of prostate cancer treatment.

Research has shown that using MRI scans in planning prostate cancer treatment can lead to better results. MRI effectively rules out severe prostate cancer cases, with a success rate of up to 95%. This confirms when a patient does not have a serious form of the disease. When combined with other methods, MRI improves the accuracy of diagnosing significant cancers. It also provides a clearer view of the cancer's stage, which can lead to changes in treatment recommendations. In this trial, participants in Arm B will undergo treatment planning with both CT and MRI scans for HDR brachytherapy. These benefits suggest that adding MRI to CT scans during brachytherapy planning could result in more precise treatments and potentially better outcomes for patients.⁶⁷⁸⁹¹⁰